256 related articles for article (PubMed ID: 33331774)
1. Potential Roles of the Glass Transition Temperature of PLGA Microparticles in Drug Release Kinetics.
Park K; Otte A; Sharifi F; Garner J; Skidmore S; Park H; Jhon YK; Qin B; Wang Y
Mol Pharm; 2021 Jan; 18(1):18-32. PubMed ID: 33331774
[TBL] [Abstract][Full Text] [Related]
2. The effect of PLGA molecular weight differences on risperidone release from microspheres.
Kohno M; Andhariya JV; Wan B; Bao Q; Rothstein S; Hezel M; Wang Y; Burgess DJ
Int J Pharm; 2020 May; 582():119339. PubMed ID: 32305366
[TBL] [Abstract][Full Text] [Related]
3. Influence of surfactant on glass transition temperature of poly(lactic-
Liu G; Martinez R; Bhatnagar A; McEnnis K
Soft Matter; 2023 Jul; 19(28):5371-5378. PubMed ID: 37409398
[TBL] [Abstract][Full Text] [Related]
4. Formulation composition, manufacturing process, and characterization of poly(lactide-co-glycolide) microparticles.
Park K; Otte A; Sharifi F; Garner J; Skidmore S; Park H; Jhon YK; Qin B; Wang Y
J Control Release; 2021 Jan; 329():1150-1161. PubMed ID: 33148404
[TBL] [Abstract][Full Text] [Related]
5. Influence of PEGylation on PLGA nanoparticle properties, hydrophobic drug release and interactions with human serum albumin.
Samkange T; D'Souza S; Obikeze K; Dube A
J Pharm Pharmacol; 2019 Oct; 71(10):1497-1507. PubMed ID: 31385295
[TBL] [Abstract][Full Text] [Related]
6. Micelle-templated, poly(lactic-
Nabar GM; Mahajan KD; Calhoun MA; Duong AD; Souva MS; Xu J; Czeisler C; Puduvalli VK; Otero JJ; Wyslouzil BE; Winter JO
Int J Nanomedicine; 2018; 13():351-366. PubMed ID: 29391794
[TBL] [Abstract][Full Text] [Related]
7. Imaging the porous structure in the core of degrading PLGA microparticles: The effect of molecular weight.
Mylonaki I; Allémann E; Delie F; Jordan O
J Control Release; 2018 Sep; 286():231-239. PubMed ID: 30071251
[TBL] [Abstract][Full Text] [Related]
8. Physical-Chemical Characterization of Octreotide Encapsulated in Commercial Glucose-Star PLGA Microspheres.
Beig A; Feng L; Walker J; Ackermann R; Hong JKY; Li T; Wang Y; Qin B; Schwendeman SP
Mol Pharm; 2020 Nov; 17(11):4141-4151. PubMed ID: 32876463
[TBL] [Abstract][Full Text] [Related]
9. Intraductal Drug Delivery to the Breast: Effect of Particle Size and Formulation on Breast Duct and Lymph Node Retention.
Joseph MK; Islam M; Reineke J; Hildreth M; Woyengo T; Pillatzki A; Baride A; Perumal O
Mol Pharm; 2020 Feb; 17(2):441-452. PubMed ID: 31886676
[TBL] [Abstract][Full Text] [Related]
10. Effect of Manufacturing Variables and Raw Materials on the Composition-Equivalent PLGA Microspheres for 1-Month Controlled Release of Leuprolide.
Zhou J; Walker J; Ackermann R; Olsen K; Hong JKY; Wang Y; Schwendeman SP
Mol Pharm; 2020 May; 17(5):1502-1515. PubMed ID: 32074448
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
[TBL] [Abstract][Full Text] [Related]
12. Micro vs. nano: PLGA particles loaded with trimethoprim for instillative treatment of urinary tract infections.
Brauner B; Schwarz P; Wirth M; Gabor F
Int J Pharm; 2020 Apr; 579():119158. PubMed ID: 32081799
[TBL] [Abstract][Full Text] [Related]
13. rhBMP-2 release from injectable poly(DL-lactic-co-glycolic acid)/calcium-phosphate cement composites.
Ruhe PQ; Hedberg EL; Padron NT; Spauwen PH; Jansen JA; Mikos AG
J Bone Joint Surg Am; 2003; 85-A Suppl 3():75-81. PubMed ID: 12925613
[TBL] [Abstract][Full Text] [Related]
14. Poly(lactic-
Maghrebi S; Joyce P; Jambhrunkar M; Thomas N; Prestidge CA
ACS Appl Mater Interfaces; 2020 Feb; 12(7):8030-8039. PubMed ID: 32013379
[TBL] [Abstract][Full Text] [Related]
15. Copolymer Composition and Nanoparticle Configuration Enhance in vitro Drug Release Behavior of Poorly Water-soluble Progesterone for Oral Formulations.
Zhang Y; Zhang R; Illangakoon UE; Harker AH; Thrasivoulou C; Parhizkar M; Edirisinghe M; Luo CJ
Int J Nanomedicine; 2020; 15():5389-5403. PubMed ID: 32801695
[TBL] [Abstract][Full Text] [Related]
16. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
[No Abstract] [Full Text] [Related]
17. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and
Öztürk AA; Yenilmez E; Şenel B; Kıyan HT; Güven UM
Drug Dev Ind Pharm; 2020 Apr; 46(4):682-695. PubMed ID: 32281428
[No Abstract] [Full Text] [Related]
18. Poly-(Lactic-co-Glycolic) Acid Nanoparticles for Synergistic Delivery of Epirubicin and Paclitaxel to Human Lung Cancer Cells.
Sharma N; Kumari RM; Gupta N; Syed A; Bahkali AH; Nimesh S
Molecules; 2020 Sep; 25(18):. PubMed ID: 32947799
[TBL] [Abstract][Full Text] [Related]
19. Fabrication of chitosan/polyvinylpyrrolidone hydrogel scaffolds containing PLGA microparticles loaded with dexamethasone for biomedical applications.
Saeedi Garakani S; Davachi SM; Bagher Z; Heraji Esfahani A; Jenabi N; Atoufi Z; Khanmohammadi M; Abbaspourrad A; Rashedi H; Jalessi M
Int J Biol Macromol; 2020 Dec; 164():356-370. PubMed ID: 32682976
[TBL] [Abstract][Full Text] [Related]
20. Local drug delivery using poly(lactic-co-glycolic acid) nanoparticles in thermosensitive gels for inner ear disease treatment.
Kim DH; Nguyen TN; Han YM; Tran P; Rho J; Lee JY; Son HY; Park JS
Drug Deliv; 2021 Dec; 28(1):2268-2277. PubMed ID: 34668836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]